CL2013003285A1 - Cepas de salmonella gallinarum modificadas avirulentas; composicion farmaceutica que la usan; aditivo para piensos; procedimiento de tratamiento de la tifosis aviar infecciosa por salmonella gallinarum. - Google Patents
Cepas de salmonella gallinarum modificadas avirulentas; composicion farmaceutica que la usan; aditivo para piensos; procedimiento de tratamiento de la tifosis aviar infecciosa por salmonella gallinarum.Info
- Publication number
- CL2013003285A1 CL2013003285A1 CL2013003285A CL2013003285A CL2013003285A1 CL 2013003285 A1 CL2013003285 A1 CL 2013003285A1 CL 2013003285 A CL2013003285 A CL 2013003285A CL 2013003285 A CL2013003285 A CL 2013003285A CL 2013003285 A1 CL2013003285 A1 CL 2013003285A1
- Authority
- CL
- Chile
- Prior art keywords
- salmonella gallinarum
- typhosis
- procedure
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10351—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161487137P | 2011-05-17 | 2011-05-17 | |
US13/274,854 US8481052B2 (en) | 2011-05-17 | 2011-10-17 | Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013003285A1 true CL2013003285A1 (es) | 2014-06-13 |
Family
ID=47175080
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013003285A CL2013003285A1 (es) | 2011-05-17 | 2013-11-15 | Cepas de salmonella gallinarum modificadas avirulentas; composicion farmaceutica que la usan; aditivo para piensos; procedimiento de tratamiento de la tifosis aviar infecciosa por salmonella gallinarum. |
CL2017000232A CL2017000232A1 (es) | 2011-05-17 | 2017-01-27 | Cepas de salmonella gallinarum modificadas avirulentas; composición farmacéutica que la usan; aditivo para piensos; procedimiento de tratamiento de la tifosis aviar infecciosa por salmonellla gallinarum. (divisional solicitud 3285-2013) |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2017000232A CL2017000232A1 (es) | 2011-05-17 | 2017-01-27 | Cepas de salmonella gallinarum modificadas avirulentas; composición farmacéutica que la usan; aditivo para piensos; procedimiento de tratamiento de la tifosis aviar infecciosa por salmonellla gallinarum. (divisional solicitud 3285-2013) |
Country Status (10)
Country | Link |
---|---|
US (3) | US8481052B2 (es) |
EP (1) | EP2710116B1 (es) |
KR (1) | KR101500805B1 (es) |
CN (2) | CN107083351B (es) |
BR (1) | BR112013029677A2 (es) |
CL (2) | CL2013003285A1 (es) |
DO (1) | DOP2013000270A (es) |
ES (1) | ES2724729T3 (es) |
PE (1) | PE20141452A1 (es) |
WO (1) | WO2012157989A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8481052B2 (en) | 2011-05-17 | 2013-07-09 | Cj Cheiljedang Corporation | Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same |
KR101465605B1 (ko) * | 2013-01-25 | 2014-11-27 | 강원대학교산학협력단 | ssrAB, rpoS 및 hmp 유전자가 결손된 살모넬라 갈리나룸 균주 및 이를 유효성분으로 포함하는 가금 티프스 예방용 백신 조성물 |
US20170333493A1 (en) * | 2014-11-11 | 2017-11-23 | Ohio State Innovation Foundation | Probiotic bacteria for the prevention and treatment of salmonella |
KR101774863B1 (ko) | 2015-07-20 | 2017-09-05 | 강원대학교산학협력단 | 살모넬라증 치료를 위한 변이 균주 hid2092와 hid2114 및 이를 포함하는 살모넬라증 약제학적 조성물 |
US10576114B2 (en) | 2015-11-25 | 2020-03-03 | Universidad De Los Andes | Composition comprising bacteriophages for reducing, eliminating and/or preventing Salmonella enteritidis, Salmonella typhimurium and Salmonella paratyphi B |
CN109486714B (zh) * | 2018-12-07 | 2020-08-04 | 扬州大学 | 一种鸡伤寒沙门氏菌弱毒分离株及其应用 |
BR112021019473A2 (pt) * | 2019-03-29 | 2021-11-30 | Purina Animal Nutrition Llc | Conservante para ração animal à base de bacteriófagos |
KR102327091B1 (ko) * | 2020-06-18 | 2021-11-16 | 전남대학교 산학협력단 | 암의 치료용 살모넬라 균주 및 이의 용도 |
CN117480255A (zh) * | 2021-04-30 | 2024-01-30 | 全南大学校产学协力团 | 减毒鸡沙门氏菌菌株及其用途 |
US20220387574A1 (en) * | 2021-05-26 | 2022-12-08 | Seoul National University R&Db Foundation | Attenuated salmonella gallinarum mutant strains and uses thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996017951A2 (en) * | 1994-12-09 | 1996-06-13 | Rpms Technology Limited | Identification of genes responsible for in vivo survival of microorganisms |
DK1108034T3 (da) * | 1998-09-04 | 2008-11-10 | Emergent Product Dev Uk Ltd | Svækkede salmonella SPI2-mutanter som antigenbærere |
GB9910812D0 (en) * | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
CA2402252A1 (en) * | 2000-03-17 | 2001-09-27 | Pharmacia & Upjohn Company | Salmonella vaccine materials and methods |
KR100436740B1 (ko) * | 2003-09-20 | 2004-06-22 | 주식회사 인트론바이오테크놀로지 | 살모넬라 갈리나룸 약독주 및 이를 포함하는 가금티푸스예방용 백신 조성물 |
US20080124355A1 (en) * | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
CN101204584A (zh) * | 2007-12-17 | 2008-06-25 | 北京娜可长今国际银离子科技开发有限公司 | 以减毒沙门氏菌为载体的肿瘤疫苗及其制备方法 |
KR101070938B1 (ko) * | 2008-12-02 | 2011-10-06 | 씨제이제일제당 (주) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 |
KR101151532B1 (ko) | 2008-12-24 | 2012-05-30 | 씨제이제일제당 (주) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 |
KR101151516B1 (ko) | 2008-12-24 | 2012-05-30 | 씨제이제일제당 (주) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 |
WO2011005587A1 (en) * | 2009-06-24 | 2011-01-13 | University Of Dubuque | Vaccine compositions and methods of use to protect against infectious disease |
US8481052B2 (en) | 2011-05-17 | 2013-07-09 | Cj Cheiljedang Corporation | Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same |
-
2011
- 2011-10-17 US US13/274,854 patent/US8481052B2/en active Active
-
2012
- 2012-05-17 CN CN201610944039.8A patent/CN107083351B/zh active Active
- 2012-05-17 ES ES12785922T patent/ES2724729T3/es active Active
- 2012-05-17 BR BR112013029677A patent/BR112013029677A2/pt not_active Application Discontinuation
- 2012-05-17 EP EP12785922.1A patent/EP2710116B1/en active Active
- 2012-05-17 CN CN201280029877.2A patent/CN104053768B/zh active Active
- 2012-05-17 WO PCT/KR2012/003920 patent/WO2012157989A2/en active Application Filing
- 2012-05-17 PE PE2013002500A patent/PE20141452A1/es active IP Right Grant
- 2012-05-17 KR KR1020120052712A patent/KR101500805B1/ko active IP Right Grant
- 2012-09-14 US US13/618,169 patent/US8524243B2/en active Active
-
2013
- 2013-04-04 US US13/856,563 patent/US9192658B2/en active Active
- 2013-11-15 DO DO2013000270A patent/DOP2013000270A/es unknown
- 2013-11-15 CL CL2013003285A patent/CL2013003285A1/es unknown
-
2017
- 2017-01-27 CL CL2017000232A patent/CL2017000232A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20141452A1 (es) | 2014-10-23 |
CN107083351B (zh) | 2021-09-14 |
EP2710116A2 (en) | 2014-03-26 |
KR20120128583A (ko) | 2012-11-27 |
KR101500805B1 (ko) | 2015-03-09 |
DOP2013000270A (es) | 2014-03-31 |
BR112013029677A2 (pt) | 2017-01-24 |
US20130202643A1 (en) | 2013-08-08 |
EP2710116A4 (en) | 2014-12-24 |
ES2724729T3 (es) | 2019-09-13 |
CN104053768A (zh) | 2014-09-17 |
US8524243B2 (en) | 2013-09-03 |
CL2017000232A1 (es) | 2017-07-28 |
WO2012157989A2 (en) | 2012-11-22 |
CN107083351A (zh) | 2017-08-22 |
US20130022574A1 (en) | 2013-01-24 |
US8481052B2 (en) | 2013-07-09 |
WO2012157989A3 (en) | 2013-01-24 |
CN104053768B (zh) | 2020-10-30 |
US20120294892A1 (en) | 2012-11-22 |
US9192658B2 (en) | 2015-11-24 |
EP2710116B1 (en) | 2019-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2013003285A1 (es) | Cepas de salmonella gallinarum modificadas avirulentas; composicion farmaceutica que la usan; aditivo para piensos; procedimiento de tratamiento de la tifosis aviar infecciosa por salmonella gallinarum. | |
CL2013001282A1 (es) | Sal succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico; composicion farmaceutica que la comprende y procesos para su preparacion. | |
CL2014002077A1 (es) | Composicion farmaceutica que comprende fumarato de dimetilo; metodo de preparacion; capsula que comprende microtabletas de fumarato de dimetilo; metodo para el tratamiento, profilaxis o mejora de la esclerosis multiple. | |
BR112014010177A2 (pt) | composto, composição farmacêutica, uso do composto, e, método para a profilaxia ou tratamento de um estado ou uma condição de doença | |
BR112014010206A2 (pt) | composto, composição farmacêutica, uso de composto, e, método para a profilaxia ou tratamento de um estado ou condição de doença | |
BR112015001098A2 (pt) | composto, composição farmacêutica e método para o tratamento de uma condição de doença. | |
BR112014010179A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
CL2015001442A1 (es) | Metodo para tratar enfermedades pulmonares que comprende el uso de compuestos derivados del acido obeticolico. | |
BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
BR112015031475A2 (pt) | composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto. | |
CL2015000177A1 (es) | Composición para el tratamiento de la hiperlipidemia que comprende un derivado de oxintomodulina | |
BR112014029674A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença, utilização de um composto, conjunto para o tratamento de uma condição mediada pela quinase pim e invenção | |
BR112014003681A8 (pt) | composto, composição farmacêutica, produto de combinação farmacêutica, uso de um composto, e, método para tratar doenças ou condições | |
CL2014003165A1 (es) | Proceso mejorado para la preparación de treprostinil y derivados del mismo. | |
BR112014003296A2 (pt) | composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, método para o tratamento de uma doença ou distúrbio, conjunto para o tratamento de uma condição mediada pela quinase pim e utilização do composto | |
BR112016000489A2 (pt) | composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos | |
CL2014000543A1 (es) | Compuestos derivados de imidazopiridazinas sustituidas con amino, inhibidores de la quinasa ,mknk2; metodo de preparacion; compuestos intermediarios y su uso; composicion farmaceutica; combinacion farmaceutica; y su uso para el tratamiento del cancer. | |
BR112014008126A2 (pt) | composto, método para o tratamento, composição farmacêutica, utilização de um composto e invenção | |
ES2603028T8 (es) | Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos | |
BR112015021003A2 (pt) | composições e métodos para a produção biológica de isopreno. | |
BR112014032510A2 (pt) | composto, composição farmacêutica, método para tratar ou prevenir uma doença ou desordem, e, uso de um composto. | |
BR112014026149A2 (pt) | método para a preparação de 2,4-ácido dihidroxibutírico (2,4-dhb) e microrganismo. | |
BR112013031712A2 (pt) | composto, composição farmacêutica, métodos para preparar um composto e para o tratamento de um distúrbio ou uma doença. | |
BR112014009889A2 (pt) | compostos dissubstituídos, compostos e composição farmacêutica | |
BR112015031979A2 (pt) | letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir. |